- Home
- / Klaria
Klaria
Stock Price
KR0.6
2024-10-29
Market Capitalization
KR83 M
2024-10-29
Revenue
KR9 M
FY, 2025
Klaria Summary
Company Summary
- Overview
- Klaria Pharma Holding is a company that develops pharmaceuticals for migraine, cancer-related pain, and opioid overdoses. It offers alginate transmucosal films that transfer active drugs through the oral mucosa directly into the blood.
- Type
- Public
- Status
- Active
- Founded
- 2014
- HQ
- Uppsala, SE | view all locations
- Website
- https://www2.klaria.com/en/
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Uppsala, Uppsala län HQ
Sweden
Virdings allé 2
Klaria Financials
Summary Financials
- Revenue (FY, 2025)
- kr9.0M
- Gross profit (FY, 2025)
- kr9.0M
- Net income (FY, 2025)
- (kr38.9M)
- Cash (FY, 2025)
- kr342.0K
- EBIT (FY, 2025)
- (kr25.2M)
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026